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Abstract
Background: The low immunogenicity of neural stem/progenitor cells (NSPCs) coupled with negligible expression of MHC
antigens has popularized their use in transplantation medicine. However, in an inflammatory environment, the NSPCs
express costimulatory molecules and MHC antigens, and also exhibit certain immunomodulatory functions. Since NSPCs are
the cellular targets in a number of virus infections both during postnatal and adult stages, we wanted to investigate the
immunological properties of these stem cells in response to viral pathogen.
Methodology/Principal Findings: We utilized both in vivo mouse model and in vitro neurosphere model of Japanese
encephalitis virus (JEV) infection for the study. The NSPCs residing in the subventricular zone of the infected brains showed
prominent expression of MHC-I and costimulatory molecules CD40, CD80, and CD86. Using Flow cytometry and
fluorescence microscopy, we observed increased surface expression of co-stimulatory molecule and MHC class I antigen in
NSPCs upon progressive JEV infection in vitro. Moreover, significant production of pro-inflammatory cyto/chemokines was
detected in JEV infected NSPCs by Cytokine Bead Array analysis. Interestingly, NSPCs were capable of providing functional
costimulation to allogenic T cells and JEV infection resulted in increased proliferation of allogenic T cells, as detected by
Mixed Lymphocyte reaction and CFSE experiments. We also report IL-2 production by NSPCs upon JEV infection, which
possibly provides mitogenic signals to T cells and trigger their proliferation.
Conclusion/Significance: The in vivo and in vitro findings clearly indicate the development of immunogenicity in NSPCs
following progressive JEV infection, in our case, JEV infection. Following a neurotropic virus infection, NSPCs possibly
behave as immunogenic cells and contribute to both the innate and adaptive immune axes. The newly discovered
immunological properties of NSPCs may have implications in assigning a new role of these cells as non-professional antigen
presenting cells in the central nervous system.
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Introduction
The role of neural stem/progenitor cells (NSPCs) in brain repair
and regeneration has been well documented [1,2]. NSPCs are a
self-renewing, multi-potential population of cells which are
capable of differentiating into neurons, astrocytes and oligoden-
drocytes. Usually housed in specific neurogenic areas of the
developing and the adult brain, namely Subventricular zone (SVZ)
and hippocampus, these cells function in brain development,
memory formation as well as brain repair [3]. The regenerative
potential of NSPCs has been used extensively for transplantation
therapy in a number of brain disorders. Transplantation with
NSPCs have ameliorated the clinical features in a range of
experimental models of neurological disease, including stroke [4];
Parkinson’s disease [5]; spinal cord trauma [6]; and multiple
sclerosis [7,8]. An important characteristic feature of NSPCs that
have helped to overcome the challenges of transplantation is the
low cell surface expression of Major Histocompatibility Complex
(MHC) gene products. Both T-cells and Natural killer (NK) cells of
the host can recognize the foreign progenitors by the surface
MHC class I expression and reject the grafted cells. Many
researchers have demonstrated absence or negligible expression of
MHC class I and II antigen by early and later passaged
neurospheres, which protects these cells from immune recognition
[9]. The low immunogenicity of NSPCs [10] coupled with their
low expression of MHC class I and II have popularized their use in
transplantation medicine [11,12].
In recent years, the immunological properties of NSPCs and
how different exogenous factors influence their immunogenicity
have begun to be explored. Previous reports indicate that the
isolated NSPCs express costimulatory molecules, like CD80 (B7.1)
and CD86 (B7.2), though their exact functions have not been
elucidated. Exposure of NSPCs to an inflammatory environment
triggers the expression of these costimulatory molecules like
increased CD80 expression in the SVZ during the course of
EAE [13]. Moreover, enhanced expression of CD80 and CD86, as
well as MHC class I (but not MHC class II), is observed in vitro
upon exposure of NSPCs to pro-inflammatory cytokines like IFN-
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c and TNF-a (the prototypical Th1 cytokines) [13,14]. The
functional relevance of enhanced expression of costimulatory and
MHC proteins on NSPCs was shown in the ability of these cells to
costimulate T-cells and trigger their proliferation [13,15]. In an
inflammatory milieu, T-cells can interact with NSPCs in vitro, but
whether such an interaction occurs in vivo is still unknown.
The role of NSPCs in immunomodulation, i.e. in regulating the
immune functions of other immune effector cells has been
established in recent years. Several reports indicate that NSPCs
can inhibit inflammatory process in cases of chronic recurrent
CNS inflammation like autoimmune diseases MS/EAE. Trans-
planted NSPCs are able to persist in chronic inflamed environ-
ment in the areas of brain damage, by means of cross-talk with the
infiltrating T-cells and the peripheral immune system [16,17]. The
immunomodulatory functions of human NSPCs have also been
shown in conditions of spinal cord injury, acute and chronic EAE
(animal models of MS) and neurodegenerative conditions [18].
Considering the immunogenic role of NSPCs and the immune-
regulation that they exert, we wanted to investigate how these cells
would behave in neurotropic virus infections. Most viruses
infecting the CNS cause acute neuroinflammation, characterized
by astrocytic and microglial activation and release of pro-
inflammatory molecules [19,20]. While research on the role of
inflammatory stimuli in triggering immunogenicity in NSPCs has
been underway, however, the immunological response of these
cells following an acute viral attack in the CNS has never been
explored. The CNS normally is in an immunologically quiescent
state, due to deficient expression of MHC molecules, and limited
entry of infiltrating T-cells into the brain parenchyma. However,
following infection with RNA viruses, induction of both innate and
adaptive immune response occur within the CNS [21]. Infection
in neurons or other CNS cell types leads to rapid local production
of type I Interferons (IFN) in a bid to curtail virus spread and
replication. The damaged and infected neurons also secrete an
array of cytochemokines, which in turn activate the resident CNS
immune cells, astrocytes and microglia [22]. Astrocytic and
microglial activation results in an inflammatory surge, and
constitutes the non-specific innate immune response to virus
infections. The virus-specific adaptive immune response follows,
accompanied by the entry of circulating leukocytes into the CNS.
Trans-endothelial migration of activated T-cells occurs and they
are retained in the CNS when the viral antigen along with the
appropriate MHC molecule is presented.
Emerging evidences have identified NSPC population as a
potential target of neurotropic viruses, and many of these viruses
establish latent infection in these cells. DNA viruses like
Cytomegalovirus, RNA viruses like Lymphocytic Choriomeningi-
tis virus (LCMV), Coxsackievirus, and Japanese encephalitis virus
(JEV) and Retroviruses like HIV are examples of such viruses
showing tropism for NSPCs. It is therefore imperative to study the
immunological response of NSPCs following viral infection and
whether these cells are able to establish a cross talk with the innate
and adaptive immune axis of the host defense mechanism. This
study for the first time have investigated the immunological
properties of NSPCs following a virus infection (JEV infection) and
have hypothesized how these cells may signal to T-cells for
development of a potent immune response against virus infection.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by Institutional Animal and Ethics Committee
of National Brain Research Center (NBRC/IAEC/2008/41),
according to the guidelines set by Committee for the Purpose of
Control and Supervision of Experiments on Animals (CPCSEA),
Ministry of Environment and Forestry, Government of India.
Virus Generation and Infection in Animals
The GP78 strain of JEV was propagated in suckling BALB/c
mice and their brains were harvested when symptoms of sickness
were observed. A 10% tissue suspension was made in minimum
essential medium (MEM), followed by centrifugation at 10,000X g
and finally filtered through a 0.22 mm sterile filter. The titration of
virus particles was done by plaque formation using PS (Porcine
stable Kidney) cell line [23]. Briefly, PS cell monolayers were
incubated with 10-fold dilutions of the virus made in MEM
containing 1% FBS for 1 hour at 37uC. After removal of viral
inoculum, monolayers were overlaid with MEM containing 4%
FBS, 1% low melting point agarose and a cocktail of antibiotic-
antimyotic solution. Plates were incubated at 37uC for 72 hours till
plaques were visible. The plaques were then counted after fixing
the cells with 10% formaldehyde and staining with crystal violet
[23,24].
Suckling BALB/c mice of either sex were injected intra-
cerebrally with ,100 p.f.u (in 30 mL of PBS) of virus, and control
animals received the same amount of PBS. From third day post
infection (dpi), animals showed symptoms of JE including limb
paralysis, poor pain response, and whole body tremor. On 4 dpi,
all animals succumbed to infection.
Neurosphere Generation and Virus Infection
BALB/c mouse pups (postnatal day 7) were decapitated and
SVZ was dissected out aseptically in PGM buffer (Phosphate
buffer with 1 mM MgCl2 and 0.6% glucose) [25]. The tissue was
then dissociated in a solution of 2 mg/ml Papain with 50 mg/ml
DNaseI at 37uC for 10 mins and neutralized with DMEM
containing 10% FBS. Following two washes with DMEM
containing 10% FBS, the cell pellet was resuspended Dulbecco’s
modified eagles Media/F12 (DMEM- F12) containing B27
supplement and 50 mg/ml gentamycin (all from Gibco, Carlsbad,
CA). The suspension was passed through 40 mm screen and then
centrifuged at 300 g for 6 mins. The cells were plated at density of
36104 cells/cm2 in DMEM F12 containing B27 and gentamycin,
supplemented with 20 mg/ml EGF (Epidermal Growth Factor)
and 10 mg/ml FGF (Fibroblast Growth Factor; R&D Systems,
Minneapolis, MN). Fresh media was added after every 2 days. All
in vitro experiments with neurospheres were carried out after
minimum 2 passages and under cell density of 1.56106 cells/
100 mm in petridishes.
The dissociated NSPCs after one day growth in suspension were
infected with JEV at MOI= 5 (Multiplicity of Infection) for 1 hour
at 37uC, washed by centrifugation, and cultured with fresh media
supplemented with growth factors. Uninfected (control) and JEV
infected neurospheres were collected at 1 day to 4 day post
infection and subsequently processed for Flow cytometry or other
co-culture experiments.
Immunohistochemistry and Immunocytochemistry
Cryosections (20 microns) were obtained from brains of JEV
infected animals and age matched controls. Fluorescence immu-
nohistochemistry was performed on the sections for the following
antibodies: anti-CD40, anti-CD80, anti-CD86, anti-H-2kd, (all
1:100, BD Biosciences, San Jose, CA), and anti-Nestin (1:250;
Chemicon, Temecula, CA). For all costimulatory and MHC
molecules, rat IgG2ak (1:100) was used as isotype control, whereas
for Nestin, normal mouse serum (1:250) was used. Antigen
retrieval using Antigen Unmasking solution (Vector Labs,
Immuno-Competency of NSPCs
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Burlingame, CA) was done, followed by blocking with appropriate
serum for 2 hours. All antibodies were incubated overnight at 4uC
in a humid chamber. Respective secondary antibodies were used-
anti-rat Biotinylated followed by Streptavidin-FITC (1:250, Vector
Labs) for costimulatory molecules and MHC-I, and anti-mouse
Alexa Fluor 594 (1:1000, Molecular Probes, Eugene, OR) for
Nestin.
The grown neurospheres were plated on PDL (Poly D-lysine)
coated chamber slides and allowed to adhere for 3 hours. The
spheres were fixed in 4% formaldehyde for 20 mins at RT,
following which they were incubated in blocking solution for 1 hr
at room temperature (RT). They were then stained for anti-CD40,
anti-CD80, anti-CD86, anti-H-2kd (all 1:100, BD Biosciences),
and finally mounted with DAPI. Images were obtained using LSM
510 confocal microscope and Zeiss Apotome microscope (Zeiss,
Germany).
Cytokine Bead Array (CBA)
Cell lysates of control and JEV infected neurospheres were
isolated using previously described protocol [26]. 50 ml of bead
mix from Mouse Inflammation CBA kit (BD Biosciences) and
50 ml of cell lysate were incubated together for 2 hours at RT in
dark. The beads were then washed and resuspended in 300 ml of
Wash buffer. The beads were acquired using Cell Quest Pro
Software in FACS Calibur and analyzed using BD CBA software
(Becton Dickinson, San Diego, CA). Standard curve was prepared
by incubating 50 ml of standard with 50 ml of bead mix.
Mixed Lymphocyte Reaction
Splenocytes were obtained from C57BL/6 mice and enriched
for T-cells by magnetic bead separation using T-cell enrichment
set according to manufacturer’s instructions (BD Biosciences). The
purity of T-cells was tested by CD3 staining in Flow cytometry
(.90% CD3+ purity). Control (uninfected) and JEV infected
NSPCs (3 dpi) were treated with mitomycin C (500 mg/ml) for
4 hours and washed twice with PBS. These mitomycin treated
NSPCs, either control or JEV infected were used as stimulators in
the mixed lymphocyte reaction. The purified splenic T cells were
used as the responders. 16105 cells of mitomycin treated NSPCs
were incubated with 26105 purified splenic T-cells in 96-well
plates in RPMI media supplemented with 10% FBS, 2 mM
Glutamine and 500 mM b-ME. The co-culture experiments were
maintained at 37uC and 5% CO2 for 72–80 hours. MTS reagent
(Promega, Madison, USA) was then added (20 ul in each well) and
following incubation for 2–3 hours, absorbance was measured at
490 nm. These experiments were performed in triplicate. Data
were represented as stimulator index, calculated as the mean
reading of triplicate wells stimulated with stimulator NSPCs,
divided by the mean reading of triplicate wells stimulated with
medium [27].
Cell Division Analysis Using CFSE Staining
The purified splenic T cells were labeled with 5-(and 6-)
carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular
Probes) at a concentration of 5 mM for 8 mins in 1% BSA
containing PBS at 37uC [28]. The cells were washed several times
with serum containing media, and then tested for cell viability
using Trypan blue exclusion method. The CFSE labeled T cell
population was then cultured alone, or co-cultured with control
and JEV infected NSPCs (3 dpi and without mitomycin C
treatment) in supplemented RPMI media. Following co-culture
for 72–80 hours, the cells were harvested and stained with CD3
antibody, and flow cytometry was performed.
Flow Cytometry
Control and JEV infected neurospheres were dissociated into
single cell suspension using Accutase treatment for 5–6 mins at
37uC with gentle shaking. The cells were washed with DMEM-
F12, and then with staining buffer, counted and finally
resuspended in FACS staining buffer (PBS with 3% FBS and
0.09% sodium azide). The cells were then stained with the desired
antibodies, CD40, CD80, CD86, MHC class I (H-2kd) and rat
IgG2ak isotype controls (BD Biosciences) for 45 mins on ice.
Following washes with staining buffer, secondary antibody, anti-
rat FITC was added for 30 mins on ice. The cells were finally
washed and analyzed in FACS Calibur. For all conditions, 20,000
events were acquired and histograms for staining were plotted.
Since neurospheres are a heterogeneous population of stem and
progenitor cells, often multiple peaks are present in the histograms.
The mean fluorescent intensity (MFI) was determined for each of
the peaks in individual condition. The average MFI of all the
peaks for a particular condition was calculated and plotted as
representative graphs.
In co-culture experiments of NSPCs with CFSE labeled T-cells,
the total cell population was resuspended in FACS staining buffer.
Following incubation with anti-CD3e antibody (a kind gift from
Dr. Satyajit Rath, National Institute of Immunology, New Delhi)
for 30 mins on ice, PE-labeled anti-rat secondary antibody was
used for 30 mins on ice. After extensive washes with FACS buffer,
the cells were acquired in FACS Calibur. Gates were set on live
lymphocyte population and analyzed for CD3 on FL2 and CFSE
on FL1 channel using Cell Quest Pro software.
RNA Extraction and Quantitative Real Time-PCR (qRT-
PCR)
Total cellular RNA was isolated from control and JEV infected
neurospheres at different dpi using RNAeasy Mini Kit (Qiagen,
Hamburg, Germany). Random hexamer primers were used for
cDNA synthesis using Advantage RT-PCR (Clontech, Mountain
View, CA). The forward and reverse primers for IL-2 (Genebank
Acc No. NM_008366.2) were 59-GCAACTGTGGTGGAC-
TTTCTGA- 39 and 59-GAGGGCTTGTTGAGATGATGCT-
39 respectively. 500 ng of cDNA was used as a template for
performing qRT-PCR using SYBR Green Supermix (Bio-Rad,
Hercules, CA) on ABI Prism 7700 sequence detection system
(Applied Biosystems, Foster City, CA). The conditions for real
time PCR were as follows: 95uC for 3 min (1 cycle), 94uC for 20 s,
55uC for 30 s, and 72uC for 40 s (40cycles). The dissociation
curves were generated to check for the specificity of primer
annealing to the template. The real time PCR results were
analyzed using the iCycler Thermal Cycler Software (Applied
Biosystems, Foster City, CA) and normalized with those from 18S
rRNA internal control.
Statistical Analysis
Statistical analysis was performed on all experiments using
paired two-tailed Student’s t-test. A statistical p value of 0.05 was
considered significant.
Results
Expression of Costimulatory Molecules and MHC Class I
in SVZ during JE Progression
We have previously reported that the infected SVZ harbours a
high viral load of JEV compared to other brain areas. During the
course of JEV infection, the Nestin positive (+) cells in the SVZ
undergo morphological alterations as well as decrease in their cell
Immuno-Competency of NSPCs
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number [25]. We therefore wanted to investigate the expression
profile of different costimulatory molecules in the SVZ of infected
animals. Immunohistochemistry was performed on control and
JEV infected sections (4 dpi) for Nestin along with all the
costimulatory molecules and MHC class I antigens. Nestin labels
all cells in the SVZ with stem cell property, including neural stem
cells, ependymal cells and neural progenitor/precursor cells. In
control animals, Nestin + cells in the SVZ show elongated
processes and very low expression of all the costimulatory
molecules and MHC class I, as detected by dual immunofluores-
cence using confocal microscopy (Fig. 1 C, E, G, I). Following JEV
infection, the expression of CD40, CD80, CD86 as well as MHC
class I showed a prominent increase, and was completely
colocalised with Nestin + cells in the SVZ (Fig. 1 D, F, H, J).
The striking morphological change in Nestin + cells from cells with
elongated process like structures to oval or round shaped cells was
observed, which is in concordance with our earlier findings [25].
Furthermore, the expression of the costimulatory and MHC class I
proteins on Nestin + cells in the JEV infected brain was mainly
localised to the surface and partially to the cytoplasm as detected
by co-localisation studies with the nuclear stain DAPI (Fig S1).
These figures clearly indicate that the surface expression of
costimulatory and MHC class I molecules underwent an increase
in the Nestin positive cells in the SVZ of JEV infected animals.
Expression of Costimulatory Molecules and MHC Class I
Protein In Vitro by NSPCs during Progressive Infection
NSPCs were isolated from SVZ of BALB/c mouse pups and
cultured in serum free media supplemented with growth factors as
free-floating clusters of cells called neurospheres. These spheres
expressed nestin [25] and when cultured in differentiation media
formed both neurons and astrocytes. After two passages, NSPCs
were either uninfected or JEV infected (MOI=5) and collected at
1 dpi, 2 dpi, 3 dpi and 4 dpi to evaluate progressive infection in
them. Using flow cytometry, we determined the expression of both
costimulatory and MHC class I molecules on both control
(uninfected) and JEV infected NSPCs at different dpi. Control
NSPCs showed negligible expression of costimulatory molecules,
Figure 1. Upregulation of costimulatory molecules and MHC class I in Nestin-positive cells in SVZ during JEV infection. Brain
cryosections from control and JEV infected animals were stained with antibodies against CD40, CD80, CD86, and MHC class I molecules and Nestin.
Isotype staining using rat IgG2ak (for costimulatory molecules and MHC class I) and normal mouse serum (NMS; for Nestin) was performed on both
control (A) and JEV infected brain sections (B). Co-localization of Nestin (red) with the costimulatory molecules and MHC class I (green) was
performed using confocal microscopy. Isotype staining on both control and JEV infected sections show no detectable fluorescence (A–B). The Nestin
+ve cells show a distinctive morphological change following infection from process bearing cells to round/oval shaped cells. Nestin positive cells in
control sections show very less co-localization with all the costimulatory molecules and MHC class I (C, E, G, I). JEV infected SVZ show complete and
increased co-localisation of Nestin positive cells with CD40 (D), CD80 (F), CD86 (H), and MHC class I (J). Scale bar corresponds to 20 microns.
doi:10.1371/journal.pone.0008134.g001
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CD40, CD80, and CD86, comparable to isotype controls.
Interestingly, with progressive JEV infection, the surface expres-
sion of all these molecules underwent a gradual increase with
increasing dpi (Fig. 2A i–iv). The mean fluorescent intensity (MFI)
for each of these surface costimulatory molecules was calculated as
an average of the MFI from multiple peaks in all the 4 conditions-
isotype control, isotype JEV infected, control neurospheres and
JEV infected neurospheres. The graphs representing averaged
MFI values show a similar pattern of expression for costimulatory
and MHC class I molecules in infected NSPCs- a gradual increase
till 3 dpi, and a sharp decline at 4 dpi (Fig. 2A v–viii). Significant
upregulation of CD40, CD80 and CD86 was observed in JEV
infected NSPCs at 3 dpi only compared to uninfected controls and
JEV infected isotype controls (Fig. 2A i, ii, iii v, vi, vii) (p,0.05).
MHC class I expression in the JEV infected NSPCs also
demonstrated a progressive increase, with robust expression at
3 dpi, which declined drastically at 4 dpi. The expression of MHC
class I on JEV infected NSPCs was elevated significantly over
control NSPCs and infected isotype controls at 2 and 3 dpi (Fig. 2A
iv, viii). MHC class II expression however remained unaltered post
JEV infection (data not shown).
Furthermore, immunocytochemistry was performed on control
and JEV infected (3 dpi) neurospheres for both costimulatory
molecules and MHC class I antigens. Since flow cytometry
revealed maximum expression of these molecules on 3 dpi of JEV
infection, we have chosen this time point for immunocytochem-
istry to further validate the surface expression of immunological
molecules by infected NSPCs (Fig. 2B). The JEV infected
neurospheres showed high surface expression of the costimulatory
molecules compared to control neurospheres and infected isotypes.
The robust expression of MHC class I was also seen upon virus
infection and was confined to the surface of these NSPCs.
Induction of Different Cytokines in NSPCs upon
Progressive JEV Infection
Previous studies have reported that TNF-a induces the
production of chemokines like CCL2 and IP-10 from human
neural precursor cells [29]. It is also established that JEV infection
leads to massive upregulation of inflammatory cytokine levels [19],
and neurons also respond to infection by secreting CCL2, and type
I and II IFNs [21]. We therefore hypothesized that virus infection
in NSPCs would also trigger the production of various cyto/
chemokines. To test the hypothesis, control and JEV infected
neurospheres at different time points of infection (1 dpi–4 dpi)
were collected and cell lysates were prepared from them. CBA was
performed using the cell lysate and bead mixture and the
production of different cytokines was assessed. We found a
significant increase in TNF-a, IFN-c, IL-6 and CCL-2 production
in JEV infected neurospheres compared to lysates from uninfected
control (Fig. 3) (p,0.005). While TNF-a, IFN-c, and IL-6 levels
showed significant elevation from 2 dpi onwards (Fig. 3 A–C) the
level of chemokine CCL2 was up-regulated as early as 1 dpi and
showed a progressive increase till 4 dpi of JEV infection (Fig. 3D).
Thus, the production of all the cyto/chemokines increased
multifold in infected NSPCs and possibly contribute to the
development of inflammatory upheaval in the CNS following JEV
infection.
JEV Infected NSPCs Are Capable of Providing Functional
Costimulation to T-Cells
Since high surface expression of CD40, CD80 and CD86 along
with MHC class I was observed in NSPCs upon JEV infection, it
was important to establish the functional significance of such
expression. The ability of NSPCs to interact with allogenic T-cells
has already been shown and the NSPC:T cell conjugate formation
has been favored upon stimulation of NSPCs with IFN- c, i.e. in
an inflammatory environment [13]. We therefore tested whether
JEV infected NSPCs were able to provide functional costimulation
to allogenic T cells. Control and JEV infected NSPCs at 3 dpi
were collected and treated with mitomycin C, which arrests their
cell cycle and growth. Mitomycin C treated control and infected
NSPCs were used as stimulators in an allogenic mixed lymphocyte
culture with purified T cells from C57/BL6 as responders. In a
control experiment, the purified T cells were cultured in
supernatant obtained from virus infected NSPCs, to rule out the
effect of the viral antigen on proliferation of T cells (data not
shown). The stimulator index was calculated as described before,
and that of T cells was considered as 1. Co-culture with JEV
infected NSPCs yielded a significantly higher stimulation index for
T cells compared to co-culture with control NSPCs (Fig. 4A)
(p,0.05). In other words, JEV infected NSPCs were able to
stimulate T-cell proliferation significantly compared to control
NSPCs where minimal T cell proliferation was observed.
The proliferative response of T cells in an allogenic reaction was
further confirmed by performing CFSE labeling experiments.
Purified T cells from C57/BL6 mice were CFSE labeled and
either cultured alone or co-cultured with NSPCs as stimulators for
72–80 hours. The total cell population was collected and then
stained with anti-CD3e antibody and subjected to flow cytometry.
On a live lymphocyte gate, the decrease of CFSE label in the
CD3+ T cell population was studied (Fig. 4B). The CD3+/CFSE
low population (upper left quadrant of dot plot) was quantified and
we found 9.762.2% of T cells undergoing proliferating when co-
cultured with control neurospheres. Interestingly, co-culture with
JEV infected neurospheres increased the percentage of these
proliferating T-cells (CD3+/CFSE low) to 18.162.96%, almost a
2 fold induction in proliferation (p,0.01). Thus, JEV infected
NSPCs induced the proliferation of allogenic T cells significantly
over control NSPCs, establishing the ability of the infected NSPCs
to provide functional costimulation to T cells.
Expression of IL-2 mRNA by NSPCs upon JEV Infection
Previous reports have highlighted the role of NSPCs in
immunomodulation and regulation of Th1/Th2 balance by
secretion of various immunomodulatory cytokines like TGF-b
[18]. However, no evidence exists regarding the expression of
cytokines like IL-2 which may influence T cell growth and
proliferation. qRT-PCR was performed for detecting IL-2 mRNA
expression using cDNA from control and JEV infected NSPCs at
different time points of infection, from 1 dpi to 4 dpi. Interestingly,
we observed that the NSPCs were capable of expressing IL-2
mRNA, whose levels underwent a significant increase upon JEV
infection (Fig. 5) (p,0.01). The maximum increase in mRNA
levels was noted at 2 dpi and 3 dpi of JEV infection. The
expression of IL-2 by NSPCs possibly indicates a role of these cells
in modulating the proliferation of T-cells. The enhanced IL-2
production upon JEV infection, therefore implicate that NSPCs
trigger T cell proliferation and may contribute to the adaptive
immune axis in the CNS.
Discussion
The CNS has long been regarded as a privileged site that is
exempted from immune surveillance, mainly due to the presence
of physical barriers, like the blood - brain barrier and the blood-
CSF barrier, and the virtual absence of CNS lymphatic system.
However, increasing evidences have challenged this view and has
Immuno-Competency of NSPCs
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Figure 2. Increased surface expression of costimulatory molecules and MHC class I by NSPCs following JEV infection in vitro. NSPCs
isolated from the SVZ were cultured as free-floating neurospheres and infected with JEV at MOI = 5. Following infection, the cells were cultured and
collected at different time points from 1 dpi to 4 dpi. Control and JEV infected NSPCs were stained with anti-CD40, anti-CD80, anti-CD86, and anti-
MHC class I and isotype controls (IgG2ak) antibodies, and analyzed using BD FACS Calibur system. The histograms were plotted and the mean
fluorescent intensity (MFI) was calculated over all the existing peaks in each of different conditions and finally represented graphically as the
averaged MFI for each condition (2A). Significant increase in surface expression of CD40 (2A i, v), CD80 (2A ii, vi) and CD86 (2A iii, viii) was noted
at 3 dpi in JEV infected NSPCs. MHC class I (2A iv, viii) expression was upregulated significantly at both 2 and 3 dpi in the infected NSPCs compared
to control NSPCs and JEV infected isotype. # indicates p,0.05 compared to control NSPCs and infected isotypes. Control and JEV infected
neurospheres at 3 dpi were collected and allowed to adhere on PDL-coated chamber slides for 3 hours and immunostained for CD40, CD80, CD 86
and MHC class I molecules, as well as rat IgG2ak isotype (2B). The nuclear counterstain was done with DAPI (blue). Increased surface expression of all
the costimulatory molecules (CD40, 80, 86) was observed in infected neurospheres. Robust surface staining for MHC class I was noticed in the
infected NSPCs compared to uninfected control. Scale bar corresponds to 20 microns.
doi:10.1371/journal.pone.0008134.g002
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supported the existence of an innate immune system within the
brain. Besides the role of glial cells, mainly microglia and
astrocytes in evoking an innate immune response to any pathogen,
the neural elements also respond to pathogen attack in unique
ways. Recent evidence from transplantation medicine have
strongly supported that NSPCs interact with the immune system,
by expression of various immune-relevant molecules. NSPCs have
been shown to express cell adhesion molecules, integrins and
chemokine receptors that allow them to interact with an inflamed
CNS microenvironment [30].
In this study we have investigated the immunological properties
of NSPCs following neurotropic viral infection (JEV infection in
our case) and how these NSPCs interact with the different immune
axes. A number of RNA viruses invade the CNS and infect the
NSPCs to establish either lytic or latent infection in these cells.
Here, we show for the first time that virus infection triggers
immunogenicity in NSPCs and the possible mechanisms by which
these infected NSPCs may contribute to the generation of host
immune response.
To assess the immunogenic potential of virus infected NSPCs,
we have determined the production of different cytokines and
chemokines by these NSPCs using Cytokine Bead Array. Indeed,
JEV infection in NSPCs increased the production of TNF-a, IFN-
c, IL-6 and CCL2. Both TNF-a and IFN-c are prototypical Th1
cytokines, whose expression are linked to macrophage activation
and subsequent inflammatory processes. Moreover, rapid local
production of IFN-c is an important survival strategy in most virus
infections of the CNS. This type II interferon contributes to the
innate immune response of the host by slowing viral spread and
limiting viral replication before the induction of specific adaptive
immune response [21]. The other cytokine IL-6 is a pleiotropic
cytokine that promotes astrocyte proliferation and astrogliosis, as
well as activation of brain macrophages [31]. JEV infected NSPCs
also secrete the chemokine CCL2, a potent monocyte chemoat-
tractant that signals to peripheral blood monocytes and activated
T cells which express its receptor CCR2 [32,33]. Thus, expression
of IL-6 and CCL2 by JEV infected NSPCs aid in the recruitment
of monocytes and activated T cells into the CNS, and thereby
mount an immunological response against the virus.
We have previously reported that during the course of JEV
infection, the SVZ is damaged and the NSPC pool is depleted,
eventually leading to a deficit in CNS repair and regeneration.
The infection of NSPC pool in the SVZ results in morphological
alterations and proliferation arrest of this putative stem cell
population, which may culminate in impaired neurogenesis [25].
In an experimental model of JEV infection, we have observed that
the Nestin positive cells express and up-regulate the expression of
costimulatory molecules, CD40, CD80 and CD86 on their
surface. Nestin typically is a marker for both neural stem and/or
progenitor cells lying in the neurogenic niches of the brain. In
neurosphere cultures also, which constitute a heterogeneous
population of neural stem and progenitor cells, we have observed
that with progressive JEV infection, there is a significant increase
in expression of CD40 and both B7 molecules. Significant
Figure 3. Production of inflammatory cytokines by NSPCs upon JEV infection. Control and JEV infected neurospheres were collected at 1–
4 dpi and cell lysates were prepared. CBA was performed with the cell lysates and the graphs represent the concentration of the different cytokines
produced. Significant production of TNF-a (A), IFN-c (B), IL-6 (C), and CCL2/MCP-1 (D) was observed in JEV infected NSPCs compared to control
NSPCs, and the levels of all cyto/chemokines reached the maximum at 3 dpi and 4 dpi. Values represent the means 6 SEM from three independent
experiments. * indicates p,0.005 compared to control.
doi:10.1371/journal.pone.0008134.g003
Immuno-Competency of NSPCs
PLoS ONE | www.plosone.org 7 December 2009 | Volume 4 | Issue 12 | e8134
expression of all these costimulatory molecules was noted at 3 dpi,
the time point which we presume when maximum viral load is
present in these NSPCs. Previous reports have indicated
expression of costimulatory molecules in the CNS following viral
infection, mainly by astrocytes and microglia, which are the
resident immune cells of the CNS [31,34]. Moreover, it has been
reported that costimulatory molecules are also expressed by cells
which are not considered professional Antigen Presenting Cells
(APC) like neurons [35], fibroblasts [36] etc. Therefore, the
expression of all the costimulatory molecules indicates that the
NSPCs might have some role in non-professional antigen
presentation following viral invasion.
There has been lot of controversy regarding MHC expression in
NSPCs, and earlier most studies have demonstrated low surface
expression of both MHC class I and class II. Recently, however,
MHC class I expression in NSPCs from mouse, rat and humans
has been documented, and both murine and human NSPCs are
able to trigger an allogenic reaction and stimulate the proliferation
of allogenic T-cells [13,15]. We also show upon JEV infection, the
surface expression of MHC class I (but not class II) on NSPCs
increased robustly at 2 and 3 dpi in vitro. High expression of MHC
class I on the Nestin positive cells in the SVZ of infected animals
Figure 4. Stimulation of T cell proliferation by NSPCs upon JEV infection. Control and JEV infected NSPCs were dissociated into single cell
suspension and treated with mitomycin C. Purified splenic T cells were used as responders and co-cultured with control and infected NSPCs
(stimulators) for 72 hours. MTS reagent was used to detect proliferation and absorbance was measured at 490 nm. Experiments were performed in
triplicate. The graph represents the stimulator index (SI), which shows that JEV infected NSPCs have a higher stimulator index, i.e. stimulate greater T
cell proliferation compared to control NSPCs (A). * indicates p,0.05 compared to control. Purified splenic T cells were labeled with CFSE and then
cultured alone or co-cultured with control and JEV infected NSPCs for 72–80 hours. The cells were then stained for anti-CD3e antibody and analyzed
by FACS. The dot plots represent the population of CD3 detected on FL2 channel and CFSE label on FL1 channel. The decrease of CFSE staining is an
indication of proliferation and we quantified the percentage of CD3 +ve cells, which have low CFSE label (upper left quadrant of dot plots) (B). JEV
infected NSPCs induced T cell proliferation by 2 fold compared to control NSPCs (p,0.01).
doi:10.1371/journal.pone.0008134.g004
Figure 5. Induction of IL-2mRNA expression by NSPCs upon JEV
infection. RNA was isolated from control and JEV infected NSPCs at
different dpi and cDNA was prepared from them. qRT-PCR was
performed for IL-2 mRNA and normalised to 18S rRNA internal control.
The graph represents the relative expression of IL-2 in JEV infected NSPCs
at different dpi compared to control NSPCs. A significant increase in IL-2
mRNA levels was observed in JEV infected NSPCs from 1 dpi to 3 dpi
compared to control NSPCs. * indicates p,0.01 compared to control.
doi:10.1371/journal.pone.0008134.g005
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was also observed. Our observations support previous studies
showing induction of both classical and non-classical MHC class I
antigens after JEV infection, but not of MHC class II [37]. The
immune properties of NSPCs are very similar to those of neurons,
which also rarely express MHC class I molecules [38], but may be
induced to express high levels of MHC class I after axotomy or
lesions, treatment with cytokines, and viral infections [39,40,41].
MHC class I signaling has been shown to be important for
synaptic plasticity during normal development as well as during
axonal regeneration following axotomy or lesions [41,42].
Therefore, the high expression of MHC class I by the infected
NSPCs, may suggest a role of MHC signaling in these cells to aid
in functional recovery from viral infection.
We further demonstrate that high costimulatory molecule
expression on virus infected neurospheres is immunologically
functional, i.e. JEV infected NSPCs are able to costimulate T cells.
Both Mixed Lymphocyte reaction and CFSE experiments have
validated that co-culture of allogenic T cells with JEV infected NSPCs
can stimulate T-cell proliferation significantly compared to co-culture
with uninfected NSPCs. Besides providing functional costimulation,
the virus infected neurospheres also provide mitogenic signals for T-
cell proliferation and activation. IL-2, a Th1 cytokine induces clonal
expansion of T cells during an immune response without determining
the antigen specificity [43]. Though previous reports have shown no
detectable expression of IL-2 mRNA in human NSPCs even after
stimulation with IFN-c and TNF-a, we observed conspicuous
induction of IL-2 mRNA in mouse NSPCs cells by qRT-PCR.
JEV infection in NSPCs induced the expression of IL-2 mRNA,
which reached its peak at 2–3 dpi. Thus, it can be clearly stated that
NSPCs stimulate the adaptive immune response by production of
Th1 cytokines, which in turn regulate the proliferation of T cells.
To summarize, murine NSPCs may respond to neurotropic
virus infection by:
N i) Production of different cytokines and chemokines like IFN-c
and IL-6, which activate the prototypical immune cells of the
brain, mainly astrocytes and microglia. IFN-c also contributes
to the generation of an innate immune response to viral
infection. Soluble mediators released from infected NSPCs
activate microglia and stimulate production of cytochemokines
like TNF-a, IL-6, IFN-c and CCL2 (unpublished observa-
tions).
N ii) Certain cyto/chemokines like TNF-a and CCL2 increase
the expression of cell adhesion molecules on endothelial cells
and aid in infiltration of peripheral T-cells and monocytes by
crossing the Blood Brain Barrier.
N iii) Uupregulation of costimulatory molecules and MHC class I
expression upon virus infection on NSPCs allows these cells to
effectively costimulate T cells and also trigger their prolifer-
ation (via IL-2 production). Thus, the NSPCs may also act on
Figure 6. Schematic representation of the possible role of NSPCs in induction of an immune response to virus infection. Following
JEV infection, NSPCs secrete an array of cyto/chemokines which help in the generation of an innate immune response against the viral pathogen. IFN-
c and IL-6 released form JEV infected NSPCs serve to activate the astrocytes and microglia, the primary immune cells of the CNS. Furthermore, both
TNF-a and CCL2 have proven roles in upregulation of cell adhesion molecules on the endothelial cells of the blood brain barrier. These cell adhesion
molecules help in recruitment of the activated T cells and monocytes from the periphery, which can now easily enter the CNS. On the other hand, JEV
infection leads to upregulation of surface expression of costimulatory molecules like CD40, CD80, CD86 as well as MHC class I antigens on NSPCs.
These costimulatory molecules and MHC class I on NSPCs are capable of providing functional co-stimulation to T cells and promote their proliferation.
Furthermore, infected NSPCs also produce IL-2 which provides mitogenic signals for T cell proliferation. Thus, infected NSPCs are capable of
stimulating the adaptive immune system, but whether the formation of an immunological synapse with T cells occurs is still under investigation.
doi:10.1371/journal.pone.0008134.g006
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the adaptive immune axis and help in generation of antigen/
virus specific immune response.
Here, we have identified the immunological properties of
NSPCs in response to virus infection, and have proposed a model
describing how these infected NSPCs may modulate both the
innate and adaptive immune system in the CNS (Fig. 6). Recently
it has been shown that NSPCs modulate T cell mediated immune
response by release of various soluble mediators [28]. We are
unable to conclusively state at this point whether the infected
NSPCs trigger the proliferation of CD4+ or CD8+ T cells, and
future work is underway to identify the responding T cell
population. Existing reports show the formation of an immuno-
logical synapse between the NSPC and T cell, and how the
formation increases in an inflammatory environment [13]. The
ability of infected NSPCs to form a functional immunological
synapse with T cells and cross-present viral antigens also needs to
be deciphered. Further insights about the immuno-competency of
these cells in combating any infection or insult will help to identify
a new function of these cells in non-professional antigen
presentation in the injured CNS. The immunological role played
by NSPCs in RNA virus infections has been proven, but their
interaction with the other immune components both in the CNS
and in the periphery needs to be further elucidated.
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